UNSPSC 51203202: Mycophenolate mofetil hydrochloride

This classification denotes an inosine monophosphate dehydrogenase inhibitor and immunosuppressant with the molecular formula C23H31NO7.ClH, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier UXH81S8ZVB, chemically known as 4-hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, hydrochloride, (e)- but more generally known as mycophenolate mofetil hydrochloride, which bears US NIH Compound Identifier 6441022.

UNSPSC 51203202 Mycophenolate mofetil hydrochloride, a Commodity code, nominally names a specific immunosuppressant pharmaceutical product, but the recent state and local opportunities posted under this code do not reflect procurement of mycophenolate mofetil itself. Instead, the tagged solicitations show demand for other pharmaceutical products — Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets through a piggyback warehouse contract, and Naloxone and drug deactivation systems through a county community health procurement. The code shows little relevant recent activity aligned with its stated product scope. State and local health agencies and counties are the issuing bodies appearing in the recent record, but the pharmaceutical products actually being solicited diverge significantly from the code's nominal classification.

The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 under Bid Number 26-482DPH-PREPD-B-53392, totaling $2,999,999.11 over the contract life including renewals, for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets with a 12-month initial term and two optional renewal years. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026 for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023, with a two-year initial term and one-year renewal option. The mismatch between the code's stated product and the actual pharmaceutical procurements appearing in the recent opportunities record suggests this code may be incorrectly tagged in state and local systems or carries limited current activity in the state and local procurement channel.